Parental ferric hydroxide saccharate therapy for iron deficiency anemia: Safety and efficacy.

被引：0
|
作者：
Abdel-Razeq, H [1 ]
Radwi, G [1 ]
Khalil, M [1 ]
Bajouda, A [1 ]
Macalintal, M [1 ]
机构：
[1] King Fahad Armed Forces Hosp, Dept Med, Jeddah, Saudi Arabia
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.3681.3681
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3681
引用
收藏
页码：6B / 6B
页数：1
相关论文
共 50 条
  • [41] Effectiveness and safety of ferric carboxymaltose to treat iron deficiency anemia in cancer patients.
    Aktas, Burak Yasin
    Kayku, Vildan Eda
    Aslan, Alma
    Kertmen, Neyran
    Dizdar, Omer
    Yalcin, Suayib
    Aksoy, Sercan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Intravenous iron gluconate or iron saccharate for patients with iron deficiency anemia with malabsorption or oral iron intolerance.
    Bulvik, S
    Karalnick, S
    Leibovitz, G
    Benist, A
    Niven, M
    BLOOD, 1997, 90 (10) : 2733 - 2733
  • [43] Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure
    Ambrosy, Andrew P.
    von Haehling, Stephan
    Kalra, Paul R.
    Court, Emma
    Bhandari, Sunil
    McDonagh, Theresa
    Cleland, John G. F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 152 : 138 - 145
  • [44] Evaluation of the efficacy and safety of intravenous infusion of ferric derisomaltose in the treatment of iron deficiency anemia:a single-center retrospective analysis
    丁少雪
    China Medical Abstracts(Internal Medicine), 2024, 41 (03) : 184
  • [45] Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women
    Shim, Jae-Yoon
    Kim, Moon Young
    Kim, Young Ju
    Lee, Young
    Lee, Jeong Jae
    Jun, Jong Kwan
    Shin, Jong Chul
    Cho, Yong Kyoon
    Lee, Keun Young
    Kim, Ahm
    Song, Tae-Bok
    BMC PREGNANCY AND CHILDBIRTH, 2018, 18
  • [46] Safety and Efficacy of High Dose Intravenous Ferric Carboxymaltose vs. Standard Medical Care in the Treatment of Iron Deficiency Anemia
    Barish, Charles
    Bregman, David
    Butcher, Angelia
    Koch, Todd
    Morris, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S406 - S407
  • [47] A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia
    Onken, Jane E.
    Bregman, David B.
    Harrington, Robert A.
    Morris, David
    Acs, Peter
    Akright, Bruce
    Barish, Charles
    Bhaskar, Birbal S.
    Smith-Nguyen, Gioi N.
    Butcher, Angelia
    Koch, Todd A.
    Goodnough, Lawrence T.
    TRANSFUSION, 2014, 54 (02) : 306 - 315
  • [48] A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: TheFERWON-EXTtrial
    Achebe, Maureen M.
    Glaspy, John
    Kalra, Philip A.
    Auerbach, Michael
    Thomsen, Lars L.
    Bhandari, Sunil
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (10) : E276 - E279
  • [49] Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women
    Jae-Yoon Shim
    Moon Young Kim
    Young Ju Kim
    Young Lee
    Jeong Jae Lee
    Jong Kwan Jun
    Jong Chul Shin
    Yong Kyoon Cho
    Keun Young Lee
    Ahm Kim
    Tae-Bok Song
    BMC Pregnancy and Childbirth, 18
  • [50] Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications
    Bailie, George R.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2010, 60 (6A): : 386 - 398
12345